Amy W Schulman - Net Worth and Insider Trading

Amy W Schulman Net Worth

The estimated net worth of Amy W Schulman is at least $10 Million dollars as of 2024-07-16. Amy W Schulman is the Executive Vice President of Pfizer Inc and owns about 227,003 shares of Pfizer Inc (PFE) stock worth over $7 Million. Amy W Schulman is the Director of Alnylam Pharmaceuticals Inc and owns about 8,436 shares of Alnylam Pharmaceuticals Inc (ALNY) stock worth over $2 Million. Amy W Schulman is also the Director of Zoetis Inc and owns about 5,000 shares of Zoetis Inc (ZTS) stock worth over $889,900. Besides these, Amy W Schulman also holds Cyclerion Therapeutics Inc (CYCN) , SQZ Biotechnologies Co (SQZB) . Details can be seen in Amy W Schulman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Amy W Schulman has not made any transactions after 2024-06-25 and currently still holds the listed stock(s).

Transaction Summary of Amy W Schulman

Amy W Schulman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Amy W Schulman owns 13 companies in total, including Alnylam Pharmaceuticals Inc (ALNY) , Cyclerion Therapeutics Inc (CYCN) , and Hudson Executive Investment Corp (HECCU) among others .

Click here to see the complete history of Amy W Schulman’s form 4 insider trades.

Insider Ownership Summary of Amy W Schulman

Ticker	Comapny	Transaction Date	Type of Owner
ALNY	Alnylam Pharmaceuticals Inc	2024-06-25	director
CYCN	Cyclerion Therapeutics Inc	2019-04-08	director
HECCU	Hudson Executive Investment Corp	2020-06-08	director
		2017-01-01	director
		2017-11-15	director
		2018-04-24	director
		2015-06-09	director
		2013-05-15	Senior Vice President
		2013-02-06	director
		2021-12-13	director & 10 percent owner
		2020-06-08	director
		2021-01-25	director
		2021-01-25	director

Amy W Schulman Latest Holdings Summary

Amy W Schulman currently owns a total of 5 stocks. Among these stocks, Amy W Schulman owns 227,003 shares of Pfizer Inc (PFE) as of May 15, 2013, with a value of $7 Million and a weighting of 67.69%. Amy W Schulman owns 8,436 shares of Alnylam Pharmaceuticals Inc (ALNY) as of June 25, 2024, with a value of $2 Million and a weighting of 22.13%. Amy W Schulman also owns 5,000 shares of Zoetis Inc (ZTS) as of February 6, 2013, with a value of $889,900 and a weighting of 9.12%. The other 2 stocks Cyclerion Therapeutics Inc (CYCN) , SQZ Biotechnologies Co (SQZB) have a combined weighting of 1.06% among all his current holdings.

Latest Holdings of Amy W Schulman

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
PFE	Pfizer Inc	2013-05-15	227,003	29.10	6,605,787
ALNY	Alnylam Pharmaceuticals Inc	2024-06-25	8,436	256.07	2,160,207
ZTS	Zoetis Inc	2013-02-06	5,000	177.98	889,900
CYCN	Cyclerion Therapeutics Inc	2019-04-08	31,681	2.92	92,509
SQZB	SQZ Biotechnologies Co	2021-12-13	301,955	0.04	11,172

Holding Weightings of Amy W Schulman

Amy W Schulman Form 4 Trading Tracker

According to the SEC Form 4 filings, Amy W Schulman has made a total of 0 transactions in Pfizer Inc (PFE) over the past 5 years. The most-recent trade in Pfizer Inc is the sale of 70,000 shares on May 15, 2013, which brought Amy W Schulman around $2 Million.

According to the SEC Form 4 filings, Amy W Schulman has made a total of 2 transactions in Alnylam Pharmaceuticals Inc (ALNY) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Alnylam Pharmaceuticals Inc is the sale of 8,500 shares on June 25, 2024, which brought Amy W Schulman around $2 Million.

According to the SEC Form 4 filings, Amy W Schulman has made a total of 0 transactions in Zoetis Inc (ZTS) over the past 5 years. The most-recent trade in Zoetis Inc is the acquisition of 5,000 shares on February 6, 2013, which cost Amy W Schulman around $130,000.

More details on Amy W Schulman's insider transactions can be found in the Insider Trading History of Amy W Schulman table.

Insider Trading History of Amy W Schulman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Amy W Schulman Trading Performance

GuruFocus tracks the stock performance after each of Amy W Schulman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Amy W Schulman is -6.89%. GuruFocus also compares Amy W Schulman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Amy W Schulman within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Amy W Schulman's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Amy W Schulman

Average Return

Average return per transaction

Outperforming Transactions

0 out of 4 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	11.58
Relative Return to S&P 500(%)	9.08

Amy W Schulman Ownership Network

Ownership Network List of Amy W Schulman

No Data

Ownership Network Relation of Amy W Schulman

Amy W Schulman Owned Company Details

What does Alnylam Pharmaceuticals Inc do?

Who are the key executives at Alnylam Pharmaceuticals Inc?

Amy W Schulman is the director of Alnylam Pharmaceuticals Inc. Other key executives at Alnylam Pharmaceuticals Inc include EVP & Chief Commercial Officer Yvonne Greenstreet , EVP & Chief Commercial Officer Tolga Tanguler , and CMO & EVP Dev & Med Affairs Pushkal Garg .

Alnylam Pharmaceuticals Inc (ALNY) Insider Trades Summary

Over the past 18 months, Amy W Schulman made 2 insider transaction in Alnylam Pharmaceuticals Inc (ALNY) with a net sale of 30,200. Other recent insider transactions involving Alnylam Pharmaceuticals Inc (ALNY) include a net sale of 32,670 shares made by Pushkal Garg , a net sale of 29,998 shares made by Yvonne Greenstreet , and a net sale of 8,607 shares made by Tolga Tanguler .

In summary, during the past 3 months, insiders sold 84,555 shares of Alnylam Pharmaceuticals Inc (ALNY) in total and bought 0 shares, with a net sale of 84,555 shares. During the past 18 months, 221,731 shares of Alnylam Pharmaceuticals Inc (ALNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 221,731 shares.

Alnylam Pharmaceuticals Inc (ALNY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Alnylam Pharmaceuticals Inc Insider Transactions

No Available Data

What does Cyclerion Therapeutics Inc do?

Who are the key executives at Cyclerion Therapeutics Inc?

Amy W Schulman is the director of Cyclerion Therapeutics Inc. Other key executives at Cyclerion Therapeutics Inc include Chief Scientific Officer Andreas Busch , director & Chief Executive Officer Peter M Hecht , and 10 percent owner Slate Path Capital Lp .

Cyclerion Therapeutics Inc (CYCN) Insider Trades Summary

Over the past 18 months, Amy W Schulman made no insider transaction in Cyclerion Therapeutics Inc (CYCN). Other recent insider transactions involving Cyclerion Therapeutics Inc (CYCN) include a net sale of 8 shares made by Terrance Mcguire ,

In summary, during the past 3 months, insiders sold 0 shares of Cyclerion Therapeutics Inc (CYCN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8 shares of Cyclerion Therapeutics Inc (CYCN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 8 shares.

Cyclerion Therapeutics Inc (CYCN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cyclerion Therapeutics Inc Insider Transactions

No Available Data

What does Hudson Executive Investment Corp do?

Who are the key executives at Hudson Executive Investment Corp?

Amy W Schulman is the director of Hudson Executive Investment Corp. Other key executives at Hudson Executive Investment Corp include director & President & Chairman Douglas L Braunstein , director & Chief Executive Officer Douglas Bergeron , and 10 percent owner Hec Sponsor Llc .

Hudson Executive Investment Corp (HECCU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Hudson Executive Investment Corp (HECCU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Hudson Executive Investment Corp (HECCU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Hudson Executive Investment Corp (HECCU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Hudson Executive Investment Corp Insider Transactions

No Available Data

What does Ironwood Pharmaceuticals Inc do?

Who are the key executives at Ironwood Pharmaceuticals Inc?

Amy W Schulman is the director of Ironwood Pharmaceuticals Inc. Other key executives at Ironwood Pharmaceuticals Inc include SVP & Chief Business Officer Andrew Davis , Chief Legal Officer Minardo John , and CMO,SVP,Head-Res&Drug Michael Shetzline .

Ironwood Pharmaceuticals Inc (IRWD) Insider Trades Summary

Over the past 18 months, Amy W Schulman made no insider transaction in Ironwood Pharmaceuticals Inc (IRWD). Other recent insider transactions involving Ironwood Pharmaceuticals Inc (IRWD) include a net sale of 435,922 shares made by Thomas A Mccourt , a net sale of 45,736 shares made by Andrew Davis , and a net sale of 84,392 shares made by Michael Shetzline .

In summary, during the past 3 months, insiders sold 226,641 shares of Ironwood Pharmaceuticals Inc (IRWD) in total and bought 0 shares, with a net sale of 226,641 shares. During the past 18 months, 807,305 shares of Ironwood Pharmaceuticals Inc (IRWD) were sold and 53,676 shares were bought by its insiders, resulting in a net sale of 753,629 shares.

Ironwood Pharmaceuticals Inc (IRWD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ironwood Pharmaceuticals Inc Insider Transactions

No Available Data

What does X4 Pharmaceuticals Inc do?

Who are the key executives at X4 Pharmaceuticals Inc?

Amy W Schulman is the director of X4 Pharmaceuticals Inc. Other key executives at X4 Pharmaceuticals Inc include Chief Scientific Officer Arthur Taveras , Chief Operating Officer Mary Dibiase , and See Remarks Adam S. Mostafa .

X4 Pharmaceuticals Inc (XFOR) Insider Trades Summary

Over the past 18 months, Amy W Schulman made no insider transaction in X4 Pharmaceuticals Inc (XFOR). Other recent insider transactions involving X4 Pharmaceuticals Inc (XFOR) include a net sale of 401,923 shares made by Paula Ragan , a net sale of 113,683 shares made by Mary Dibiase , and a net sale of 401,921 shares made by Adam S. Mostafa .

In summary, during the past 3 months, insiders sold 0 shares of X4 Pharmaceuticals Inc (XFOR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,158,291 shares of X4 Pharmaceuticals Inc (XFOR) were sold and 25,000 shares were bought by its insiders, resulting in a net sale of 1,133,291 shares.

X4 Pharmaceuticals Inc (XFOR)'s detailed insider trading history can be found in Insider Trading Tracker table.

X4 Pharmaceuticals Inc Insider Transactions

No Available Data

What does Blue Buffalo Pet Products Inc do?

Who are the key executives at Blue Buffalo Pet Products Inc?

Amy W Schulman is the director of Blue Buffalo Pet Products Inc. Other key executives at Blue Buffalo Pet Products Inc include director & President and CEO Bishop William W Jr , director & 10 percent owner Artal Group S.a. , and director & 10 percent owner Artal International S.c.a. .

Blue Buffalo Pet Products Inc (BUFF) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Blue Buffalo Pet Products Inc (BUFF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Blue Buffalo Pet Products Inc (BUFF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Blue Buffalo Pet Products Inc (BUFF)'s detailed insider trading history can be found in Insider Trading Tracker table.

Blue Buffalo Pet Products Inc Insider Transactions

No Available Data

What does DNIB Unwind Inc do?

Who are the key executives at DNIB Unwind Inc?

Amy W Schulman is the director of DNIB Unwind Inc. Other key executives at DNIB Unwind Inc include director & other: Chairman Daniel Lynch , Chief Scientific Officer Jonathan Michael Yingling , and director & PRESIDENT & CEO Andrew Hirsch .

DNIB Unwind Inc (BINDQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of DNIB Unwind Inc (BINDQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DNIB Unwind Inc (BINDQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

DNIB Unwind Inc (BINDQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

DNIB Unwind Inc Insider Transactions

No Available Data

What does Pfizer Inc do?

Who are the key executives at Pfizer Inc?

Amy W Schulman is the Senior Vice President of Pfizer Inc. Other key executives at Pfizer Inc include Executive Vice President Christoffel Boshoff , SVP & Controller Jennifer B. Damico , and Executive Vice President Payal Sahni .

Pfizer Inc (PFE) Insider Trades Summary

Over the past 18 months, Amy W Schulman made no insider transaction in Pfizer Inc (PFE). Other recent insider transactions involving Pfizer Inc (PFE) include a net purchase of 5,000 shares made by Scott Gottlieb , and a net sale of 9,912 shares made by Jennifer B. Damico .

In summary, during the past 3 months, insiders sold 0 shares of Pfizer Inc (PFE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 9,912 shares of Pfizer Inc (PFE) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 4,912 shares.

Pfizer Inc (PFE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Pfizer Inc Insider Transactions

No Available Data

What does Zoetis Inc do?

Who are the key executives at Zoetis Inc?

Amy W Schulman is the director of Zoetis Inc. Other key executives at Zoetis Inc include Executive Vice President Roxanne Lagano , Executive Vice President Kristin C Peck , and Executive Vice President Heidi C. Chen .

Zoetis Inc (ZTS) Insider Trades Summary

Over the past 18 months, Amy W Schulman made no insider transaction in Zoetis Inc (ZTS). Other recent insider transactions involving Zoetis Inc (ZTS) include a net sale of 31,366 shares made by Roxanne Lagano , a net sale of 52,000 shares made by Kristin C Peck , and a net sale of 9,905 shares made by Heidi C. Chen .

In summary, during the past 3 months, insiders sold 923 shares of Zoetis Inc (ZTS) in total and bought 0 shares, with a net sale of 923 shares. During the past 18 months, 95,820 shares of Zoetis Inc (ZTS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 95,820 shares.

Zoetis Inc (ZTS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Zoetis Inc Insider Transactions

No Available Data

What does SQZ Biotechnologies Co do?

Who are the key executives at SQZ Biotechnologies Co?

Amy W Schulman is the director & 10 percent owner of SQZ Biotechnologies Co. Other key executives at SQZ Biotechnologies Co include See Remarks Richard Capasso , Chief Medical Officer Marshelle Smith Warren , and 10 percent owner American International Group, Inc. .

SQZ Biotechnologies Co (SQZB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of SQZ Biotechnologies Co (SQZB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of SQZ Biotechnologies Co (SQZB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

SQZ Biotechnologies Co (SQZB)'s detailed insider trading history can be found in Insider Trading Tracker table.

SQZ Biotechnologies Co Insider Transactions

No Available Data

What does Talkspace Inc do?

Who are the key executives at Talkspace Inc?

Amy W Schulman is the director of Talkspace Inc. Other key executives at Talkspace Inc include Chief Product Officer Steven Dziedzic , General Counsel and Secretary John Charles Reilly , and Chief Technology Officer Gil Margolin .

Talkspace Inc (TALK) Insider Trades Summary

Over the past 18 months, Amy W Schulman made no insider transaction in Talkspace Inc (TALK). Other recent insider transactions involving Talkspace Inc (TALK) include a net sale of 94,018 shares made by ,

In summary, during the past 3 months, insiders sold 94,018 shares of Talkspace Inc (TALK) in total and bought 0 shares, with a net sale of 94,018 shares. During the past 18 months, 94,018 shares of Talkspace Inc (TALK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 94,018 shares.

Talkspace Inc (TALK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Talkspace Inc Insider Transactions

No Available Data

What does Hudson Executive Investment Corp II do?

Who are the key executives at Hudson Executive Investment Corp II?

Amy W Schulman is the director of Hudson Executive Investment Corp II. Other key executives at Hudson Executive Investment Corp II include Chief Financial Officer Ira Mosberg , director & other: President & Chairman Douglas L Braunstein , and director & Chief Executive Officer Douglas Bergeron .

Hudson Executive Investment Corp II (HCIIU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Hudson Executive Investment Corp II (HCIIU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Hudson Executive Investment Corp II (HCIIU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Hudson Executive Investment Corp II (HCIIU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Hudson Executive Investment Corp II Insider Transactions

No Available Data

What does Hudson Executive Investment Corp II do?

Who are the key executives at Hudson Executive Investment Corp II?

Hudson Executive Investment Corp II (HCII) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Hudson Executive Investment Corp II (HCII) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Hudson Executive Investment Corp II (HCII) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Hudson Executive Investment Corp II (HCII)'s detailed insider trading history can be found in Insider Trading Tracker table.

Hudson Executive Investment Corp II Insider Transactions

No Available Data

Amy W Schulman Mailing Address

Above is the net worth, insider trading, and ownership report for Amy W Schulman. You might contact Amy W Schulman via mailing address: Pfizer Inc. Attn: Corporate Secretary, 235 East 42nd Street, New York Ny 10017.

Discussions on Amy W Schulman

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.